DE60118981D1 - Verfahren zur inaktivierung von prionen in lipoproteinen - Google Patents
Verfahren zur inaktivierung von prionen in lipoproteinenInfo
- Publication number
- DE60118981D1 DE60118981D1 DE60118981T DE60118981T DE60118981D1 DE 60118981 D1 DE60118981 D1 DE 60118981D1 DE 60118981 T DE60118981 T DE 60118981T DE 60118981 T DE60118981 T DE 60118981T DE 60118981 D1 DE60118981 D1 DE 60118981D1
- Authority
- DE
- Germany
- Prior art keywords
- lipoprotein
- lipoproteins
- inactivating prions
- prions
- inactivating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28963701P | 2001-05-08 | 2001-05-08 | |
| US31497001P | 2001-08-24 | 2001-08-24 | |
| PCT/US2001/031505 WO2002090379A1 (en) | 2001-05-08 | 2001-10-09 | Process for inactivating prions in lipoproteins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE60118981D1 true DE60118981D1 (de) | 2006-05-24 |
Family
ID=26965759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60118981T Expired - Lifetime DE60118981D1 (de) | 2001-05-08 | 2001-10-09 | Verfahren zur inaktivierung von prionen in lipoproteinen |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US6743899B2 (de) |
| EP (1) | EP1385871B1 (de) |
| AT (1) | ATE323715T1 (de) |
| AU (1) | AU2002211544A1 (de) |
| DE (1) | DE60118981D1 (de) |
| WO (1) | WO2002090379A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002090379A1 (en) * | 2001-05-08 | 2002-11-14 | Serologicals Royalty Company | Process for inactivating prions in lipoproteins |
| US20050054003A1 (en) * | 2003-09-10 | 2005-03-10 | Stenland Christopher J. | Prion clearance using particulate metal oxides |
| CA2620047A1 (en) * | 2005-08-25 | 2007-03-01 | Detlev Riesner | Prion inactivation |
| US8293174B2 (en) | 2007-10-17 | 2012-10-23 | American Sterilizer Company | Prion deactivating composition and methods of using same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3112249A (en) | 1962-12-10 | 1963-11-26 | Commw Engineering Co Of Ohio | Process of splitting steroids |
| US4290774A (en) | 1980-01-07 | 1981-09-22 | Miles Laboratories, Inc. | Purification of lipoprotein cholesterol for use as a cholesterol reference material |
| JPS61277623A (ja) | 1985-05-10 | 1986-12-08 | マイルス・ラボラトリ−ス・インコ−ポレ−テツド | 哺乳動物の血漿または血清あるいはその分画からコレステロールに富んだ分画を単離しかつ精製する方法 |
| AT408191B (de) | 1991-08-19 | 2001-09-25 | Haemosan Erzeugung Pharmazeuti | Verfahren zur inaktivierung von prionen |
| US5514388A (en) * | 1994-08-31 | 1996-05-07 | Rohwer; Gary L. | Encapsulated lipid-containing feed |
| US5756678A (en) | 1995-05-01 | 1998-05-26 | Cohesion Technologies, Inc. | Prion inactivation in connective tissue materials |
| ATE233275T1 (de) * | 1998-02-11 | 2003-03-15 | Zlb Bioplasma Ag | Verfahren zur entfernung von erregern übertragbarer spongiformer encephalophatien aus proteinlösungen |
| WO2002090379A1 (en) * | 2001-05-08 | 2002-11-14 | Serologicals Royalty Company | Process for inactivating prions in lipoproteins |
-
2001
- 2001-10-09 WO PCT/US2001/031505 patent/WO2002090379A1/en active IP Right Grant
- 2001-10-09 US US09/974,497 patent/US6743899B2/en not_active Expired - Lifetime
- 2001-10-09 AU AU2002211544A patent/AU2002211544A1/en not_active Abandoned
- 2001-10-09 AT AT01979600T patent/ATE323715T1/de not_active IP Right Cessation
- 2001-10-09 EP EP01979600A patent/EP1385871B1/de not_active Expired - Lifetime
- 2001-10-09 DE DE60118981T patent/DE60118981D1/de not_active Expired - Lifetime
-
2004
- 2004-02-24 US US10/785,681 patent/US20040167071A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1385871A1 (de) | 2004-02-04 |
| US20030032780A1 (en) | 2003-02-13 |
| ATE323715T1 (de) | 2006-05-15 |
| US6743899B2 (en) | 2004-06-01 |
| AU2002211544A1 (en) | 2002-11-18 |
| EP1385871B1 (de) | 2006-04-19 |
| WO2002090379A8 (en) | 2003-03-20 |
| US20040167071A1 (en) | 2004-08-26 |
| WO2002090379A1 (en) | 2002-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE420947T1 (de) | Gewebeimplant zur wiederherstellung von knorpelgewebe | |
| DE69528475D1 (de) | Verwendung von serotonin-antagonisten (5ht3) zur behandlung von fibromyalgie | |
| DE60217136D1 (de) | Benzothiazepin und benzothiadiazepin derivative mit hemmender wirkung auf den säuretransport in den gallengängen zur behandlung von hyperlipidaemia | |
| ATE499103T1 (de) | Verfahren zur behandlung von arzneimittelinduzierter peripherer neuropathie und verwandten krankheitsformen | |
| ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| ATE218344T1 (de) | Ranolazin und verwandte piperazine zur behandlung von schockzuständen | |
| ATE313326T1 (de) | VERWENDUNG VON CABERGOLIN ZUR BEHANDLUNG VON ßRESTLESS LEGS SYNDROMß | |
| ATE198706T1 (de) | Polyamin-verbindungen zur behandlung von proliferativer erkrankungen | |
| DE69535264D1 (de) | Verfahren zur behandlung von diabetes mittels kgf | |
| DE69519213D1 (de) | Verfahren zur Behandlung von Kunststoff-,Leder- oder Kautschuksubstraten | |
| DE60222745D1 (de) | Verwendung von neurofilamentproteinen zur behandlung von tumoren | |
| ATE220923T1 (de) | Rekombinante adenoviren und deren verwendung in der gentherapie zur behandlung von augenerkrankungen | |
| DE60218153D1 (de) | Verwendung von proteasom-inhibitoren zur behandlung des trockenen auges | |
| DE60118981D1 (de) | Verfahren zur inaktivierung von prionen in lipoproteinen | |
| DE69900168D1 (de) | Zusammensetzung zur Behandlung von Papier und damit behandeltes Papier | |
| DE69308879D1 (de) | Methode zur behandlung von abfallverbrennungsrückständen und deren verwendung als adsorptionsmittel | |
| DE69331546T2 (de) | Verwendung von cytochrome - p 450 - inhibitoren zur hemmung des stoffwechsels von stickstoffsubstituierten acridinen | |
| DE69827387D1 (de) | Verwendung von pramipexol zur behandlung von restless-legs-syndrom | |
| ATE264101T1 (de) | Verwendung von thioamidoxazolidinonen zur behandlung von knochenresorption und osteoporose | |
| ATE360425T1 (de) | Verwendung von quetiapin für die behandlung von kokain-abhängigkeit | |
| DE60209817D1 (de) | Verfahren zur inaktivierung von amylase in gegenwart von protease | |
| ATE225181T1 (de) | Verwendung von heparinen niedrigeren molekulargewichtes zur behandlung von hirnödemen | |
| DE69711422T2 (de) | Verwendung von (r)-verapamil als medizin zur behandlung von angina | |
| ATE255417T1 (de) | Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen | |
| ATE269718T1 (de) | Verfahren zur inaktivierung von viren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de |